Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer
Open Access
- 8 July 2013
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (30), 12474-12479
- https://doi.org/10.1073/pnas.1306241110
Abstract
The physiological functions of hydrogen sulfide (H2S) include vasorelaxation, stimulation of cellular bioenergetics, and promotion of angiogenesis. Analysis of human colon cancer biopsies and patient-matched normal margin mucosa revealed the selective up-regulation of the H2S-producing enzyme cystathionine-β-synthase (CBS) in colon cancer, resulting in an increased rate of H2S production. Similarly, colon cancer-derived epithelial cell lines (HCT116, HT-29, LoVo) exhibited selective CBS up-regulation and increased H2S production, compared with the nonmalignant colonic mucosa cells, NCM356. CBS localized to the cytosol, as well as the mitochondrial outer membrane. ShRNA-mediated silencing of CBS or its pharmacological inhibition with aminooxyacetic acid reduced HCT116 cell proliferation, migration, and invasion; reduced endothelial cell migration in tumor/endothelial cell cocultures; and suppressed mitochondrial function (oxygen consumption, ATP turnover, and respiratory reserve capacity), as well as glycolysis. Treatment of nude mice with aminooxyacetic acid attenuated the growth of patient-derived colon cancer xenografts and reduced tumor blood flow. Similarly, CBS silencing of the tumor cells decreased xenograft growth and suppressed neovessel density, suggesting a role for endogenous H2S in tumor angiogenesis. In contrast to CBS, silencing of cystathionine-γ-lyase (the expression of which was unchanged in colon cancer) did not affect tumor growth or bioenergetics. In conclusion, H2S produced from CBS serves to (i) maintain colon cancer cellular bioenergetics, thereby supporting tumor growth and proliferation, and (ii) promote angiogenesis and vasorelaxation, consequently providing the tumor with blood and nutritients. The current findings identify CBS-derived H2S as a tumor growth factor and anticancer drug target.Keywords
This publication has 47 references indexed in Scilit:
- Hydrogen Sulfide Is an Endogenous Inhibitor of Phosphodiesterase ActivityArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapiesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Angiogenesis Inhibitors: Current Strategies and Future ProspectsCA: A Cancer Journal for Clinicians, 2010
- Hydrogen sulfide induces human colon cancer cell proliferation: Role of Akt, ERK and p21Cell Biology International, 2010
- Hydrogen sulfide is an endogenous stimulator of angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- H 2 S Signals Through Protein S-SulfhydrationScience Signaling, 2009
- CCK2 receptor expression transforms non‐tumorigenic human NCM356 colonic epithelial cells into tumor forming cellsInternational Journal of Cancer, 2009
- H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-LyaseScience, 2008
- Hydrogen sulphide and its therapeutic potentialNature Reviews Drug Discovery, 2007